Antibodies under a microscope

DHD17205

Research Grade Nurulimab

Description

BCD-145, CAS: 2168561-20-2

Targets

CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4

Isotype/Mimetic

IgG1-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Naive display libraries derived from human B cells

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Animal-free discovery, In vitro recombinant expression